AINV Flashcards
AINV whats the big deal
short term impact: stress/anxiety, poor QoL during tx
long term: loss of adherence to tx - cancer progression
anorexia, dehydration fatigue
define nausea, vomiting, AINV
inclination to vomit or feeling in the throat or epigastric area that vomiting is imminent
vomiting: ejection or expulsion of gastric contents thru month w involuntary muscle contractions
emesis occues when VC in brain is triggered
AINV: previously chemo induced NV (CINV)
classified as acute, delayed, anticipatory, breakthru, refractory
why does it happen?
emesis occurs when vomiting center is actived by affferent impulses
the VC sends effect impulses to salivation centra, abdominal muscles, stomach, esophagus
what are 2 ways chemo can cause vomiting
peripheral visceral vagal afferednt impulsesL iritated GIT send msg along vagal afferents, activating VC
chemo trigger zone (CTZ): lies outside of BBB in area postrema of 4th ventricle, exposed to circulating noxious drugs
nausea: may have diff mechanism
prinicpal Neuroectptors: serotonin, dopamine
others: acetylcholem corticosteroid, histamine, etc/
define acute, delayed, anticipatory, breakthru, refractory AINV
see slide 5
emetic risk of tx
determined by drug wth highest risk in combo
most imp factor in pt assessment
diff bw 4 classes of emetic risk?
slide 8
minimal <10%
low 10-30
moderate 30-90
high >90
pt specific risk factors
women >men
NV w/ previous chemo
history of motion sickness
morning sickness with pregnancy
high alcohol consumption lower risk
ager older than 50 lower risk (peds higher risk)
goals of tx and approach
goal is no NV, focus is prevention
prevent and provide strategy for breakthru
much easier to preven AINV than treat
easier to prevent vomiting than nausea
all pt need evidence based prevention regimen appropriate for their risk AND a breakthru agent
prophylaxis
5HT3 receptor antagonist
3 on market
ondansetron, granisetron, 2nd gen palonosetron
role is prevention of acute AINV. evidence lacking for delayed AINV for 1st gen
AE: constipation (1in 10 pt), QT prolongation
dexamethosone
unclear mech
goodfor prevnetion of acute and delayed
AE: short term high dose steroid AE (sleep distrubance, mood change, dyspepsia, hyperglycemia)
NK1 receptor antagonist
combin with 5HT3 +/- dex, improved efficacy for acute AND delayed
AE: well tolerated, headache (9%)
DI: CYP3A4, 2C9, dex, warfarin,OCs (contracep)
olanzapine
off label
good efficacy for preventing and also breakthrough
max daily dose is 10mg/day for AINV (higher for mental)
AE: sedation, EPS, orthostatic hypotension
prophyl of acute and delayed with parenteral HEC
HEC = highly emetic chemo
see sldie 14
pt should get 3-4 drugs
always 5HT3
usually NK1 and dex
sometimes olan
5ht3 Given on day 1, 30-60min before chemo
prophyl of acute and delayed with parenteral MEC
usually recieve 2 drugs or 3 (if oxaliplatin or carboplatin)
NK1 is common when oxaliplatin or carboplatin is present
If not it is not given
Olanzapine is rarely used